Evidence mapPaperPMID 40979703Full record

ArticleFrontiers in endocrinology2025

The blood glucose control levels and influencing factors analysis among diabetes patients in rural areas of Guangxi, China.

Jingfeng Chen, Guifen Fu, Xiaoxue Lei, Chaoqun Bai, Lina Wen, Yanping Zhang

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jingfeng Chen *Department of Geriatric Endocrinology and Metabolism, Guangxi Academy of Medical Sciences and the People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
Guifen Fu *Department of Nursing, Guangxi Academy of Medical Sciences and the People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
Xiaoxue Lei *Department of Geriatric Endocrinology and Metabolism, Guangxi Academy of Medical Sciences and the People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
Chaoqun BaiDepartment of Geriatric Endocrinology and Metabolism, Guangxi Academy of Medical Sciences and the People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
Lina WenCardiovascular Medicine Cadre Ward and Geriatric Cardiovascular Medicine Department, Guangxi Academy of Medical Sciences and the People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
Yanping ZhangDepartment of Geriatric Endocrinology and Metabolism, Guangxi Academy of Medical Sciences and the People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Diabetes mellitus is a growing public health concern in China, with the rural areas of Guangxi facing rising prevalence, poor glycemic control, and limited healthcare access despite national efforts to improve diabetes management. This study aimed to evaluate the level of glycated hemoglobin (HbA1c) control and identify associated factors among patients with diabetes in the rural areas of Guangxi, China, to inform strategies for improving diabetes management in these regions. Methods: A multistage stratified random sampling method was employed. In the first stage, five cities (Nanning, Guilin, Hechi, Chongzuo, and Yulin) were randomly selected, each representing a geographical region of Guangxi (central, eastern, southern, western, and northern). In the second stage, three counties were randomly selected from each city, yielding a total of 15 counties. One county-level hospital with a general internal medicine department was selected in each county for patient recruitment. Data on demographic characteristics (e.g., sex, age, household income, type of medical insurance, educational level, and disease duration) were collected, and laboratory testing was conducted to measure HbA1c levels. Glycemic control was defined as an HbA1c level< 7%. Multivariate logistic regression was used to identify factors associated with glycemic control. Results: A total of 2,178 patients with diabetes were included, of whom 1,204 (55.28%) were men and 974 (44.72%) were women. The mean age was 63.25 ± 12.71 years, and the mean duration of diabetes was 7.96 ± 4.07 years. The overall HbA1c control rate was 22.68%. Logistic regression analysis revealed that older age (OR = 1.026, 95% CI: 1.017-1.036), longer disease duration (OR = 1.137, 95% CI: 1.104-1.171), use of oral hypoglycemic agents (OR = 0.485, 95% CI: 0.377-0.624), insulin therapy (OR = 0.425, 95% CI: 0.388-0.534), and higher educational level (e.g., primary school: (OR = 6.507, 95% CI: 3.076-13.767); junior high school: (OR = 5.557, 95% CI: 2.818-10.955); senior high school: (OR = 2.848, 95% CI: 1.485-5.462); college: (OR = 2.479, 95% CI: 1.285-4.782); and bachelor's degree: (OR = 1.915, 95% CI: 0.943-3.889), and higher annual per capita household income (OR = 0.626, 95% CI: 0.528-0.830) were significantly associated with glycemic control ( Conclusion: The HbA1c control rate among patients with diabetes in rural Guangxi was relatively low (22.68%). Targeted interventions should focus on patients who are older, have a longer disease duration, are not receiving antidiabetic treatment, have lower educational levels, or have lower income levels to improve glycemic management in rural areas.

Indexed as

Blood GlucoseDiabetes MellitusDiabetes Mellitus, Type 2Glycemic ControlRural PopulationAdultAgedChinaCross-Sectional StudiesFemaleGlycated HemoglobinHumansMaleMiddle AgedBlood GlucoseGlycated Hemoglobinhemoglobin A1c protein, humanassociated factorsdiabetesglycated hemoglobinglycemic controlrural areas

Identifiers

PMID40979703
PMCPMC12446050

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.